Stockscreener 앱 받기
1.99
2.45%
-0.05
시간 외 거래:
1.98
-0.01
-0.50%
Cardio Diagnostics Holdings Inc 주식(CDIO)의 최신 뉴스
Cardio Diagnostics Holdings Inc (CDIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cardio Diagnostics Holdings, Inc. 2026: Revenue $5.36K, EPS ($0.51) — 10-Q Summary - TradingView
Cardio Diagnostics (NASDAQ: CDIO) Q2 2026 shows $5.6M cash and equity funding - Stock Titan
Cardio Diagnostics Holdings Inc (CDIO) Stock News Today - TradingKey
CDIO | Cardio Diagnostics Holdings Inc. Executive Compensation - Quiver Quantitative
Cardio Diagnostics (NASDAQ: CDIO) plans vote on sizable new stock issuance - Stock Titan
Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026 - Business Wire
Enterprise value to EBITDA forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView
CDIOW Warrants Hold at $0.01 as Cardio Diagnostics Faces a Critical Technical FloorDiamond Pattern - dars.gov.et
Cardio Diagnostics Holdings Inc (CDIO) Income Statement - tradingkey.com
Cardio Diagnostics Holdings Inc. Revenue Breakdown – BOATS:CDIOW - TradingView
CDIO|Cardio Diagnostics Holdings Inc|Price:1.600|Chg%:+0.050 - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Balance Sheet - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cardio Diagnostics Holdings Inc (CDIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cardio Diagnostics Holdings Inc. Revenue Breakdown – NASDAQ:CDIOW - TradingView
CDIO|Cardio Diagnostics Holdings Inc|Price:1.550|Chg%:-0.050 - TradingKey
Cardio Diagnostics Hldgs Market Sentiment - Benzinga España
Cardio Diagnostics Holdings Inc (CDIO) Institutional Confidence - TradingKey
Cardio Diagnostics Warrants See Significant Gains (CDIOW) – A Closer LookVOLD Alert - dars.gov.et
Cardio Diagnostics Holdings Inc (CDIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cardio Diagnostics (CDIO) details AI-driven heart disease testing and capital raises - Stock Titan
CDIO Q1 2025 Earnings: Narrower-Than-Expected Loss but Revenue Remains AbsentStrong Earnings Momentum - dars.gov.et
Cardio Diagnostics Holdings Inc. (CDIO) Q1 2025 Earnings: Better-than-Expected Losses but No Revenue YetEPS Growth Rate - dars.gov.et
Cardio Diagnostics Holdings Inc. Warrant (CDIOW) Surges Over 31% but Remains at Sub-Penny LevelsRating Change - dars.gov.et
What's Driving Cardio Diagnostics Holdings' Recent Stock Surge - Kavout | AI
Cardio Diagnostics Leverages AI and Precision Medicine to Address Growing Cardiovascular Disease Market - citybuzz -
Price to book forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView
Cardio Diagnostics (NASDAQ: CDIO) eyes private share issuance of up to $10M - Stock Titan
Price to earnings forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView
Enterprise value to EBIT forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW - TradingView
Heart Attack Diagnostic Market Report Examines Leading Companies And Growth Opportunities - openPR.com
Enterprise value to revenue forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIO - TradingView
CDIO Q1 2025 Earnings: Narrower-than-Expected Loss Despite Stock PullbackDividend Growth Analysis - DonanımHaber
CDIO Should I Buy - Intellectia AI
Form 4 Cardio Diagnostics Holdings Inc For: 2 July By Investing.com - Investing.com India
Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19 strike - Stock Titan
Cardio Diagnostics (NASDAQ: CDIO) director awarded 2,854 options at $2.19 - Stock Titan
Cardio Diagnostics (CDIO) director granted 2,854 stock options at $2.19 strike price - Stock Titan
Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19 - Stock Titan
Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans - NewMediaWire
Cardio Diagnostics Holdings (NASDAQ: CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans - Barchart.com
CDIO Q1 2025 Earnings: EPS Beats Estimates by 47.2% as Company Advances Diagnostic PlatformAnalyst Coverage Count - dars.gov.et
Cardio Diagnostics Highlights Precision Cardiovascular Tools for Employers and Health Plans at National Conferences - citybuzz -
Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks - TradingView
Cardio Diagnostics Uses Epigenetics to Uncover Hidden Heart Disease Risks - MEXC
Cardio Diagnostics Holdings (CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection - TipRanks
Cardio Diagnostics Holdings Warrant (CDIOW) Holds Steady at $0.01 Amid Minimal MovementValue Area Low - dars.gov.et
CDIO Q1 2025 Earnings: EPS Surpasses Consensus by Over 47% as Company Advances Diagnostic PlatformDownward Estimate Revision - dars.gov.et
Cardio Diagnostics (CDIO) Holds Near $2.01 Amid Modest Decline – Key Levels in FocusGamma Flip Level - DonanımHaber
Cardio Diagnostics Unveils Molecular Test to Address Blind Spots in Coronary Heart Disease Detection - citybuzz -
Cardio Diagnostics Holdings Inc. Actuals & Estimates (NASDAQ:CDIO) - TradingView
Cardio Diagnostics Holdings (CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians - TradingView
Atlas Healthcare will cover Cardio Diagnostics heart tests for members - Stock Titan
Cardio Diagnostics Company Profile & Introduction - Moomoo
Cardio Diagnostics Holdings (CDIO) Targets a $393B Heart Disease Problem With Epigenetics and AI - Yahoo Finance
Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets a $393B Heart Disease Problem with Epigenetics and AI - TradingView
1.80%
1.77%
자본화:
|
볼륨(24시간):